patients undergoing thoracoscopic surgery
Conditions
Interventions
Group A:0.5% ropivacaine 20ml
Group B:0.5% ropivacaine plus 5mg dexamethasone total 20ml
Group C:0.5% ropivacaine plus hydromorphone 0.5mg total 20ml
Group D:0.5% ropivacaine plus dexmedetomidine 1ug/kg total 20ml
Group E:Epidural tube
Group F:Intrathoracic paravertebral block
Sponsors
The First Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Voluntary participation in the experiment and sign the informed consent; 2. Patients with pulmonary surgery under the thoracoscope; 3. Aged 18-65 years; 4. ASAI-II level; 5. Meet the telephone follow-up conditions, the survival rate is greater than three months and cooperate with the experimenter.
Exclusion criteria
Exclusion criteria: 1. There are past pain, pregnancy, and severe liver and kidney, circulatory system diseases; 2. Patients with clutch block or epidural block failure; 3. Patients are allergic to test drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| resting pain score;coughing pain score;first pressing time of the analgesic pump;drug consumption in analgesic pumps;chronic pain;resting pain score;coughing pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood pressure;heart rate;pulse oximetry;EEG frequency double stage; | — |
Countries
China
Contacts
Public ContactSun Xijia
The First Hospital of China Medical University
Outcome results
None listed